KING PHARMACEUTICALS,INC

KG

DALLAS , Nov. 5, 2025 /PRNewswire/ -- Kestrel Group Ltd (NASDAQ: KG) ("Kestrel" or the "Company"), a leading specialty insurance platform that provides fronting services to program managers, reinsurers, and reinsurance brokers, today reported its financial results for the third quarter ended September 30, 2025. Key Highlights - Third Quarter 2025 Financials Total revenues were $17.4 million Net premiums earned were $6.8 million Net loss was $5.1 million Program Services net fee income was $1.0 million As of September 30, 2025, the Company's book value per common share was $18.57 The Company reported earnings for the second time since closing its business combination agreement on May 27, 2025 between Kestrel and Maiden Holdings.

DALLAS , Aug. 15, 2025 /PRNewswire/ -- Kestrel Group Ltd (NASDAQ: KG) ("KG" or the "Company"), today announced its financial results for the second quarter ended June 30, 2025. For further details regarding the Company's financial performance and condition, please refer to the Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, filed with the U.S. Securities and Exchange Commission, available at www.sec.gov.